President and CEO

Co-Founder

Sagimet Biosciences Announces Upcoming Panel Participation at Fierce Biotech Week

Positive Phase 3 Results for Denifanstat for the Treatment of Moderate to Severe Acne to be Presented at the EADV Congress 2025 by Partner Ascletis

Sagimet Biosciences reports data from Phase 3 trial on denifanstat

Sagimet Biosciences announces presentations at MASH Drug Development Summit

Senior Accountant

Sagimet Biosciences is seeking a highly skilled and experienced Senior Accountant to join their finance team. The role is critical in ensuring the accuracy and integrity of financial reporting and compliance with regulatory requirements, including the preparation of financial statements and audit support.

Sign up with Google

Sign in with Google